Medication info
Losartan 100 mg (Losartan Potassium)

Losartan 100 mg (Losartan Potassium)

Prescription medicationTabletOral
Ingredient · strength
Losartan Potassium›100mg / 1 tablet
Manufacturer / importer
HanKook HyuTex Pharmaceutical Co., Ltd.
Appearance
White, droplet-shaped film-coated tablets
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201904185 · Approved 2019.06.14 · Insurance code 649104480

Summary

Main use
Treatment of hypertension and nephropathy in patients with type 2 diabetes mellitus and hypertension
Who takes it
Adults · Children
Adult dose
This medicine may be taken with or without food, but it is recommended that it be taken at the same time each day. 1. Hypertension 1) Adults The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect is achieved 3 ∼ 6 weeks after starting treatment. If the treatment effect is inadequate, the same dose may be administered orally in 2 divided doses daily or, if necessary, increased to 100 mg once daily. 3) If blood pressure is not controlled with this medicine alone, it may be administered in combination with another antihypertensive agent (e.g., a low-dose diuretic). An additive effect was observed when administered with hydrochlorothiazide. 2. Nephropathy in patients with type 2 diabetes and hypertension The usual adult dose is 50 mg of this medicine once daily. The dose may be increased to 100 mg once daily depending on blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered in combination with insulin or commonly used blood glucose-lowering agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). 3. Special populations 1) Older adults No adjustment of the initial dose is necessary in older adults aged 75 or younger. For older adults over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. 2) Patients with renal impairment (1) Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. (2) Creatinine clearance < 20 mL/min and patients undergoing dialysis: An initial dose of 25 mg of this medicine once daily is recommended. 3) Patients with reduced effective intravascular volume For patients who may have reduced effective intravascular volume (e.g., patients being treated with diuretics), an initial dose of 25 mg of this medicine once daily is recommended (see Precautions for Use). 4) Patients with hepatic impairment A lower dose should be considered in patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
Child dose
Children and adolescents 6 years of age and older, weighing 20 kg or more and less than 50 kg, who are able to swallow tablets: The recommended dose is 25 mg of this medicine once daily, which may be increased to a maximum of 50mg once daily depending on the patient's blood pressure response. Children and adolescents 6 years of age and older, weighing 50 kg or more: The usual recommended dose is 50 mg of this medicine once daily, which may be increased to a maximum of 100 mg once daily depending on the patient's blood pressure response. Pediatric patients under 6 years of age: Not recommended. Pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.

Ingredients

Manufacturer
HanKook HyuTex Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of hypertension and nephropathy in patients with type 2 diabetes mellitus and hypertension

  • Hypertension
View approved original text

This medication is used for the treatment of hypertension. It is particularly effective in preventing and treating kidney disease in patients with type 2 diabetes who have hypertension. It helps manage renal complications due to hypertension and diabetes, supporting healthy kidney function. This medication lowers blood pressure and prevents kidney damage, contributing to overall health improvement.

How to take

Adult dose

This medicine may be taken with or without food, but it is recommended that it be taken at the same time each day. 1. Hypertension 1) Adults The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect is achieved 3 ∼ 6 weeks after starting treatment. If the treatment effect is inadequate, the same dose may be administered orally in 2 divided doses daily or, if necessary, increased to 100 mg once daily. 3) If blood pressure is not controlled with this medicine alone, it may be administered in combination with another antihypertensive agent (e.g., a low-dose diuretic). An additive effect was observed when administered with hydrochlorothiazide. 2. Nephropathy in patients with type 2 diabetes and hypertension The usual adult dose is 50 mg of this medicine once daily. The dose may be increased to 100 mg once daily depending on blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered in combination with insulin or commonly used blood glucose-lowering agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). 3. Special populations 1) Older adults No adjustment of the initial dose is necessary in older adults aged 75 or younger. For older adults over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. 2) Patients with renal impairment (1) Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. (2) Creatinine clearance < 20 mL/min and patients undergoing dialysis: An initial dose of 25 mg of this medicine once daily is recommended. 3) Patients with reduced effective intravascular volume For patients who may have reduced effective intravascular volume (e.g., patients being treated with diuretics), an initial dose of 25 mg of this medicine once daily is recommended (see Precautions for Use). 4) Patients with hepatic impairment A lower dose should be considered in patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.

Child dose

Children and adolescents 6 years of age and older, weighing 20 kg or more and less than 50 kg, who are able to swallow tablets: The recommended dose is 25 mg of this medicine once daily, which may be increased to a maximum of 50mg once daily depending on the patient's blood pressure response. Children and adolescents 6 years of age and older, weighing 50 kg or more: The usual recommended dose is 50 mg of this medicine once daily, which may be increased to a maximum of 100 mg once daily depending on the patient's blood pressure response. Pediatric patients under 6 years of age: Not recommended. Pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.

Precautions

This medication can cause serious harm to the fetus, especially when taken during the second and third trimesters of pregnancy; therefore, it should not be taken by pregnant women or women who may become pregnant. Additionally, it should not be administered to patients with hypersensitivity to this medication, severe liver impairment, a history of hereditary angioedema, or primary hyperaldosteronism. Elderly patients, those with hyperkalemia, liver impairment, and cardiovascular disease should use this medication cautiously, as there is a risk of significantly lowering blood pressure or worsening kidney function. This medication may cause side effects such as muscle cramps, dizziness, and upper respiratory infections, and in rare cases, serious adverse reactions such as angioedema, liver function abnormalities, and rhabdomyolysis may occur, so any unusual symptoms should be reported to healthcare professionals immediately. Particularly, this medication can increase serum potassium levels, so it should be avoided with potassium supplements or potassium-containing medications, and dizziness or fainting may occur due to its blood pressure-lowering effects, so caution is needed when driving or operating machinery. It is advisable for pregnant and nursing women to avoid this medication; if pregnancy is confirmed, the medication should be discontinued immediately, and a doctor should be consulted. This medication should not be used in pediatric patients under 6 years of age or patients with severely impaired kidney function. In cases of overdose, hypotension and tachycardia may occur, and immediate medical treatment should be sought if symptoms arise. Routine checks of blood pressure and kidney function, as well as electrolyte levels, should be conducted while taking this medication, and appropriate measures should be taken if abnormalities are detected. It is recommended not to take this medication with grapefruit juice, and due to potential interactions with other medications, patients should consult their doctor or pharmacist if they are taking other drugs.

Side effects

  • Decreased skull formation
  • anuria
  • hypotension
  • renal failure
  • muscle cramps
  • back pain
  • leg pain
  • dizziness
  • congestion
  • upper respiratory tract infection
Show 135 more
  • sinusitis
  • nausea
  • diarrhea
  • dyspepsia
  • cough
  • sinus disorders
  • pharyngitis
  • myalgia
  • insomnia
  • headache
  • weakness/fatigue
  • edema/swelling
  • abdominal pain
  • chest pain
  • lip swelling
  • eyelid swelling
  • facial rash
  • palm scaling
  • hemolysis
  • facial swelling
  • fever
  • orthostatic effects
  • fainting
  • angina
  • second-degree atrioventricular block
  • cerebrovascular accident
  • myocardial infarction
  • atrial fibrillation
  • palpitations
  • tachycardia
  • ventricular tachycardia
  • ventricular fibrillation
  • loss of appetite
  • constipation
  • toothache
  • dry mouth
  • flatulence
  • gastritis
  • vomiting
  • anemia
  • gout
  • upper limb pain
  • hip pain
  • joint swelling
  • knee pain
  • musculoskeletal pain
  • shoulder pain
  • muscle rigidity
  • arthralgia
  • arthritis
  • fibromyalgia
  • muscular weakness
  • anxiety
  • anxiety disorder
  • ataxia
  • confusion
  • depression
  • nightmares
  • sensory deficit
  • decreased libido
  • memory impairment
  • migraine
  • neuro-sensitivity
  • sensory disturbance
  • peripheral neuropathy
  • panic disorder
  • sleep disorders
  • hypersomnolence
  • tremor
  • dizziness
  • dyspnea
  • bronchitis
  • pharyngeal discomfort
  • nasal hemorrhage
  • rhinitis
  • respiratory congestion
  • chest discomfort
  • hair loss
  • dermatitis
  • dry skin
  • petechiae
  • erythema
  • flushing
  • photosensitivity reaction
  • itching
  • rash
  • sweating
  • hives
  • blurred vision
  • eye burning and pain
  • conjunctivitis
  • taste disturbance
  • tinnitus
  • decreased visual acuity
  • erectile dysfunction
  • nocturia
  • frequency of urination
  • urethral infection
  • vascular edema
  • vasculitis
  • anaphylactoid syndrome
  • liver dysfunction
  • hepatitis
  • intestinal vascular edema
  • lethargy
  • thrombocytopenia
  • myalgia
  • weakness
  • elevated creatine kinase
  • rhabdomyolysis
  • dry cough
  • erythematous skin condition
  • hyperkalemia
  • hyponatremia
  • elevated ALT
  • increased creatinine
  • increased BUN
  • decreased hemoglobin
  • decreased hematocrit
  • elevated liver enzymes
  • increased serum bilirubin
  • fainting
  • loss of consciousness
  • acute hepatitis
  • fulminant hepatitis
  • ventricular ectopic beats
  • atrial fibrillation
  • hypoglycemia
  • weakness
  • hunger
  • cold sweat
  • tremors
  • decreased concentration
  • convulsion
  • altered consciousness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to avoid exposure to air or moisture. It is best to maintain a storage temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness for a long time.

Appearance and packaging

Appearance

White, droplet-shaped film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.